Your search returned 2 results.

Results
	1.	Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program. [Review] MedStar authors: Aroda, Vanita R Peng, Hui Want, Laura L PMID: 27037706 Year: 2016 Citation: Current Diabetes Reports. 16(5):44, 2016 May. Institution: MedStar Health Research Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Review Form of publication: Journal Article All authors: Aroda VR, Peng H, Want LL DOI: http://dx.doi.org/10.1007/s11892-016-0728-4 Add to cart (remove)
	2.	Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. MedStar authors: Aroda, Vanita R PMID: 31530665 Year: 2019 Citation: Diabetes Care. 42(11):2108-2116, 2019 11. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Blonde L, Del Prato S, Frias J, Henry R, Ji C, Niemoeller E, Rosenstock J, Shehadeh N, Souhami E DOI: https://dx.doi.org/10.2337/dc19-1357 Add to cart (remove)

Refine your search